Menopause hormone therapy gets fresh look from regulators
CBS America · 25 days ago
CBS America
25 days ago
The FDA has long-mandated so-called "black box" labels on hormone therapy for menopause, warning about stroke, blood clots dementia and breast cancer. But now, regulators are considering removing some of those warnings.
Breakdown
- The FDA is considering removing some warnings from menopause hormone therapy medications. 44s
- Recent research suggests previous studies may have overstated breast cancer risks, especially for younger women. 1m 6s
- Starting hormone therapy between ages 50 and 59 may reduce risks and offer health benefits. 2m 7s
- Women with certain cancer histories may not qualify for systemic hormone therapy, but local forms could be safer. 2m 31s
- Doctors recommend individualized assessment before starting hormone therapy. 2m 20s